摘要
目的观察老年乳腺癌患者实施新辅助化疗的疗效及预后康复效果。方法选取2017年1月至2019年2月医院收治的78例乳腺癌患者,依据随机数字表法分为对照组和观察组,各39例。对照组接受常规化疗,观察组接受新辅助化疗,比较两组的临床疗效以及预后康复情况。结果治疗前后,两组CD3^+、CD4^+、CD8^+、CD4^+/CD8^+水平比较,差异均无统计学意义(P>0.05)。治疗前,两组生活质量评分对比,差异无统计学意义(P>0.05);治疗后,观察组生活质量评分高于对照组,差异有统计学意义(P<0.05)。结论采用新辅助化疗对老年乳腺癌患者进行治疗不会对患者的免疫功能造成明显影响,同时有利于改善患者预后康复效果,提高患者生活质量。
Objective To observe and analyze the curative effect and prognosis of neoadjuvant chemotherapy in elderly breast cancer patients.Methods From January 2017 and February 2019,78 patients were admitted to the hospital and all were diagnosed with breast cancer.According to the digital table method,there were a total of two groups of 39 cases.The control group received routine chemotherapy and the observation group used neoadjuvant chemotherapy.After treatment,the therapeutic effects and prognosis of the patients were compared.Results Before and after treatment,there was no significant difference in the levels of CD3^+,CD4^+,CD8^+,CD4^+/CD8^+between the two groups(P>0.05).Before treatment,the difference in quality of life scores between the two groups was not statistically significant(P>0.05);after treatment,the quality of life scores of the observation group were higher than those of the control group,and the difference was statistically significant(P<0.05).Conclusion The treatment of the elderly breast cancer patients with neoadjuvant chemotherapy will not have significant impact on the immune function of the patients,and at the same time,it was beneficial to improve the patient's prognosis and rehabilitation quality,relieve the patient's pain,improve the patient's quality of life.
作者
于显凤
YU Xianfeng(No.3 Department of Oncology,Liaoyang Central Hospital,Liaoyang 111000,China)
出处
《中国医药指南》
2020年第36期93-94,共2页
Guide of China Medicine
关键词
乳腺癌
老年
新辅助化疗
疗效
预后
Breast cancer
Elderly
Neo-adjuvant chemotherapy
Curative effect
Prognosis
